Prolacta Bioscience
PrivateLast Round
M&A
Dec 30, 2024
Total Funding Raised
$80.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Prolacta Bioscience is a life sciences company that develops and manufactures human milk-based nutritional products for critically ill and premature infants in neonatal intensive care units.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prolacta Bioscience Comparables
Compare Prolacta Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LactaLogics | 78% | |
| Abbott Laboratories | 78% | |
| Medolac Laboratories | 76% | |
Prolacta Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Dec 30, 2024 | ||||
| Series E | May 14, 2018 | ||||
| Series E | Dec 6, 2016 | ||||
| Series D | Nov 3, 2011 | ||||
| Series C | May 23, 2007 | ||||
Series B | Oct 4, 2006 |
Key People
Founding team and executive leadership
Prolacta Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DFJ Frontier | Series C |
| EW Healthcare Partners | M&A, Series E |
| Gideon Hixon Fund | Series C |
| Aisling Capital | Series E |
| Draper Associates | Series C |
| PhillipCapital Group | Series C |
| Arcturus Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 328, 101% of current headcount.
- Dec 30, 2024
EW Healthcare Partners led the M&A round.
Prolacta Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Prolacta Bioscience's valuation, stock price, and market status.